cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Beam Therapeutics Inc
84 own
18 watching
Current Price
$45.3
$1.45
(3.31%)
logo-beam
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,191.73M
52-Week High
52-Week High
80
52-Week Low
52-Week Low
27.77
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,191.73M
icon52-Week High80
icon52-Week Low27.77
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio--
What does the Beam Therapeutics Inc do?
Beam Therapeutics Inc. is a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. Beam Therapeutics Inc.principal executive offices are located at 26 Landsdowne Street, 2nd Floor, Cambridge, MA 02139
Read More
How much money does Beam Therapeutics Inc make?
News & Events about Beam Therapeutics Inc.
Zolmax
5days ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) CFO Terry-Ann Burrell sold 47,195 shares of the companys stock in a transaction that occurred on Wednesday, January 18th. The stock was sold at an average price of $45.14, for a total value of $2,130,382.30. Following the transaction, the chief ...
Zolmax
1month ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) insider Giuseppe Ciaramella sold 51,015 shares of the firms stock in a transaction on Monday, December 12th. The shares were sold at an average price of $42.70, for a total value of $2,178,340.50. Following the completion of the sale, the insider now ...
Globe Newswire
1month ago
Data from ESCAPE-1 and ESCAPE-2 Approaches to Be Presented During Poster Sessions at the 64th ASH Annual Meeting and ExpositionCAMBRIDGE, Mass., Dec. 10, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base ...
Globe Newswire
1month ago
CAMBRIDGE, Mass., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the U.S. Food and Drug Administration (FDA) has lifted the clinical hold and cleared the Investigational New...
Benzinga
2 months ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Beam Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Beam Therapeutics Inc shares?
plus_minus_icon
How can I buy Beam Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Beam Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Beam Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Beam Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Beam Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Beam Therapeutics Inc?
plus_minus_icon
What percentage is Beam Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Beam Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$45.3
$1.45
(3.31%)
logo-beam
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00